Saudi Arabia Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Changes are afoot at Blogtrottr! By popular request, we're bringing in paid plans with some cool new features (and more on the way). You can read all about it in our blog post.

Life Sciences Market Research Reports

Saudi Arabia Pharmaceuticals and Healthcare Report Q3 2013 Jul 3rd 2013, 00:00, by jitu BMI View: Saudi Arabia’s large and wealthy population will continue to support demand for patented medicines. While the country’s intellectual property (IP) environment remains below par, multinationals will remain interested in the market, as evidenced by Pfizer and Sanofi’s investment in the construction of local manufacturing and packaging facilities in the King Abdullah Economic City (KAEC), which will be used to supply the domestic and regional markets and also to reduce costs. Headline Expenditure Projections ? Pharmaceuticals: SAR20.35bn (US$5.43bn) in 2012 to SAR22.48bn (US$6.00bn) in 2013; +10.5% in both local currency and US dollar terms. Forecast broadly unchanged from Q213. … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=105200. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/saudi-arabia-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions